Results 111 to 120 of about 1,670 (156)
Phenotypic Expression and Outcomes in Patients with the p.Arg301Gln GLA Variant in Anderson-Fabry Disease. [PDF]
Blanco R +19 more
europepmc +1 more source
Expanding the Neurological Phenotype of Anderson-Fabry Disease: Proof of Concept for an Extrapyramidal Neurodegenerative Pattern and Comparison with Monogenic Vascular Parkinsonism. [PDF]
Zedde M +11 more
europepmc +1 more source
Isolated ‘cardiac Variant’ of Anderson-fabry Disease Diagnosed by CMR
Husna Mohd Zaki +10 more
doaj +1 more source
Can Amyloid and Anderson-fabry Disease Have a CMR Overlap Syndrome?
Saed Alnaimat +6 more
doaj +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Anderson–Fabry disease management: role of the cardiologist
European Heart JournalAbstractAnderson–Fabry disease (AFD) is a lysosomal storage disorder characterized by glycolipid accumulation in cardiac cells, associated with a peculiar form of hypertrophic cardiomyopathy (HCM). Up to 1% of patients with a diagnosis of HCM indeed have AFD.
Robert Desnick, , Maurizio Pieroni
exaly +5 more sources
British Journal of Dermatology, 2006
SUMMARY Electron microscopy of clinically uninvolved skin taken from a 12-month-old male child with biochemically proven angiokeratoma corporis diffusum showed characteristic lamellar lipid deposits within endothclial and perithelial cells of dermal blood vessels. Ultrastructural examination of skin may aid the early identification of males affected
Petar, Kes +3 more
+6 more sources
SUMMARY Electron microscopy of clinically uninvolved skin taken from a 12-month-old male child with biochemically proven angiokeratoma corporis diffusum showed characteristic lamellar lipid deposits within endothclial and perithelial cells of dermal blood vessels. Ultrastructural examination of skin may aid the early identification of males affected
Petar, Kes +3 more
+6 more sources
Treatment of Anderson-Fabry Disease
Current Pharmaceutical Design, 2020Fabry disease is an X-linked disorder of glycosphingolipid metabolism that results in progressive accumulation of neutral glycosphingolipids, predominantly globotriaosylsphingosine (Gb3) in lysosomes, as well as other cellular compartments of several tissues, causing multi-organ manifestations (acroparesthesias, hypohidrosis, angiokeratomas, signs ...
Irene Simonetta +4 more
openaire +2 more sources
Anderson-Fabry Disease in Children
Current Pharmaceutical Design, 2013Although clinical evidence of major organ damage is typical of adulthood, many of the signs and symptoms of Anderson Fabry Disease (AFD) occur frequently in childhood. The clinical phenotype of AFD in pediatric patients has been described in several studies which show a higher incidence and an earlier onset of symptoms in male patients than in females.
Simona, Sestito +2 more
openaire +2 more sources
Anderson-Fabry disease in Austria
Wiener Klinische Wochenschrift, 2003Fabry disease is an X-linked inherited inborn error of glycosphingolipid catabolism. The deficiency of alpha-galactosidase A leads to the deposition of glycosphingolipids primarily in lysosomes of blood vessel cells. In classically affected hemizygotes clinical manifestations include pain in the extremities, vessel ectasia (angiokeratoma) in skin and ...
Matthias, Lorenz +9 more
openaire +2 more sources
The heart in Anderson Fabry disease
Zeitschrift für Kardiologie, 2002Anderson Fabry disease is a life threatening, X-linked inborn metabolic defect of the lysosomal enzyme áalpha-galactosidase A. The deficiency of alpha-galactosidase A leads to a progressive accumulation of globotriaosylceramide (Gb(3)), the major glycosphingolipid substrate of the enzyme, within vulnerable cells, tissues, and organs, including the ...
Christoph, Kampmann +5 more
openaire +2 more sources

